Advanced Search

Study Preview



Study Title and Description

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study.
Author Jonas MM., Squires RH., Rhee SM., Lin CW., Bessho K., Feiterna-Sperling C., Hierro L., Kelly D., Ling SC., Strokova T., Del Valle-Segarra A., Lovell S., Liu W., Ng TI., Porcalla A., Gonzalez YS., Burroughs M., Sokal E.
Country Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA.
Year 2020
Numbers Pubmed ID: 31254392

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.